Advanced Optics Electronics Inc. Reports Progress in BIOMODA Inc.Business Editors ALBUQUERQUE, N.M.--(BUSINESS WIRE)--May 17, 2002 Advanced Optics Electronics Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ADOT ADOT Arizona Department Of Transportation ADOT Alaska Department of Transportation ADOT Fédération des Associations pour le Don d'Organes et de Tissus Humains ADOT Active Duty Other Than Training ADOT Automatic Digital Optical Tracker ADOT Advanced Display Optimization Tools ) biotech investment BIOMODA Inc. of which ADOT holds approximately 17.5 percent reports that it has just received notification from the Canadian government of the granting of a patent for use of Tetrakis Porphine for the detecting and treating of lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . This is a continuation of the BIOMODA Inc. program of obtaining patents on a global basis for its cancer detection technology. BIOMODA Inc. now holds international patents in addition to Canada in the following countries: Australia, Brazil, South Korea, Russia and Japan. ADOT also reports that it has made progress in preparing for BIOMODA Inc.'s IPO (Initial Public Offering) The first time a company offers shares of stock to the public. While not a computer term per se, many founders, employees and insiders of computer companies have found this acronym more exciting than any tech term they ever heard. and is in the process of finalizing its preparation for its SB-2 filing. Advanced Optics Electronics Inc. is a technology company based in Albuquerque. The company maintains an R&D facility and manufacturing plant, and is engaged in building large-scale flat panel displays A thin display screen for computer and TV usage. The first flat panels appeared on laptop computers in the mid-1980s, and the LCD technology became the standard. Stand-alone LCD screens became available for desktop computers in the mid-1990s and exceeded sales of CRTs for the first time utilizing its patented and patent-pending technology. In addition to the core business of ADOT, the company has made a strategic technology-oriented investment in BIOMODA Inc. BIOMODA Inc. (nonpublic) is a company that holds patents and patents pending domestically and internationally for the early detection of lung cancer. ADOT currently holds approximately 17 1/2 percent of BIOMODA Inc. This news release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates," and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. . |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion